MCM7 expression is increased in a variety of tumors, including hepatocellular, neuroblastoma, hypopharyngeal, prostate, and cervical carcinomas, acting as a marker for cell proliferation (Honeycutt et al. 2006, Qu et al. 2017). Here, MCM7 is linked to neuroblastoma.